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Cigarette smoking is a risk factor for stroke and is linked to stroke severity. Previous studies have shown 
that cigarette smoke extract (cSe) triggers endothelial dysfunction in vitro by initiating oxidative stress 
and/or an inflammatory response. In addition, cerebral endothelial dysfunction (particularly at the 
level of the blood-brain barrier [BBB]) contributes to stroke pathogenesis. Therefore, we hypothesized 
that cigarette smoking may influence stroke, at least in part, by exacerbating ischaemia-induced BBB 
disruption. To test this, we examined the effect of CSE on the permeability of cerebral endothelial 
cells exposed to oxygen glucose deprivation and reoxygenation (oGD + RO). We found that the loss 
of BBB integrity following ischaemic/reperfusion-like conditions was significantly worsened by CSE. 
Despite this being associated with increased mRNA expression of Nox catalytic subunits, reactive 
oxygen species (ROS) levels were however markedly lower. Furthermore, this occurred in association 
with elevated expression of antioxidant enzymes (SOD1, SOD2, and Gpx-1), suggesting an antioxidant 
defence response. Lastly, we found that CSE significantly upregulated mRNA expression of cytokines 
(IL-6 and TGF-β). Collectively, these results show that acute exposure to CSE worsens BBB disruption 
caused by oGD + RO, however, this is not linked to elevated ROS levels but may involve inflammatory 
mechanisms.
Cigarette smoking is a major cause of morbidity and mortality worldwide1. In addition to causing various can-
cers2, cigarette smoking is linked to the pathogenesis of a number of diseases that affect the brain. For example, 
smoking is a risk factor for ischaemic and haemorrhagic stroke3, and silent cerebral infarction4. Cigarette smok-
ing is also a major cause of chronic obstructive pulmonary disease (COPD), accounting for more than 95% of 
cases in industrialized countries5. Recent studies have shown that strokes are more prevalent in COPD patients 
compared with the general population6–8, and clinical studies have revealed that COPD is linked to worse stroke 
outcomes including mortality9,10. Given smoking is an established risk factor for stroke and is linked to worse 
stroke outcomes the association between COPD and stroke may be largely dependent on exposure to cigarette 
smoke6.
Cigarette smoke contains over 4,000 chemicals including nicotine and reactive oxygen species (ROS, e.g. 
superoxide, hydrogen peroxide)11. These oxidants give rise to secondary ROS by inflammatory cells within the 
lung as part of an inflammatory-immune response towards a pathogen or irritant6. These inflammatory cells also 
have an impaired phagocytic function, resulting in impairment in clearance of apoptotic cells, contributing to 
the chronic inflammatory state in the lungs and leading to an ongoing cycle of damage and remodelling in the 
airways and lung tissue12,13. In addition to triggering local oxidative stress and inflammation in the lungs, the 
chemicals found in cigarette smoke can pass through the lung and initiate oxidative stress and inflammation in 
cells remote from the primary site of exposure14,15. At the level of the cerebral vasculature this can in turn trigger 
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cerebral endothelial dysfunction6,16. Indeed, exposure of rats to cigarette smoke impairs endothelial-dependent 
vasodilator responses of cerebral arterioles in vivo by activating the Nox-NADPH oxidases17, ROS generating 
enzymes that are major contributors to cerebral endothelial dysfunction in numerous disease states including 
stroke16,18. Furthermore, using cigarette smoke extract (CSE) to mimic physiological concentrations of heavy 
smokers, several studies have shown that cigarette smoking triggers blood-brain barrier (BBB) disruption in vitro 
via oxidative and inflammatory mechanisms19,20. Given cerebral endothelial dysfunction, particularly at the level 
of the BBB, is implicated in stroke pathogenesis21, it is conceivable that cigarette smoking may influence stroke, 
at least in part, by exacerbating ischaemia-induced BBB disruption. Therefore, the aim of this study was to exam-
ine whether CSE worsens BBB disruption using a well-established in vitro BBB stroke model, and to determine 
whether this is associated with elevated ROS production and/or inflammation.
Methods
Cigarette smoke extract (CSE) preparation. CSE was prepared as previously described22. Briefly, this 
involved using one filtered Winfield Original Red cigarette (1.2 mg of nicotine, 16 mg of tar, 15 mg of CO). The 
cigarette was lit and using a 30 ml syringe cigarette smoke was bubbled (flow rate of 3 mL/second) into 25 mL of 
culture media (Dulbecco’s modified Eagle’s medium [DMEM] media). This process was repeated until the ciga-
rette had burned through just prior to the filter. The resultant solution was defined as 100% CSE. 100% CSE was 
then filtered before being diluted in media. CSE was utilised within 15–30 minutes after preparation.
Culture of mouse cerebral microvascular endothelial cells. Mouse microvascular cerebral endothe-
lial cells (bEnd.3 cells; ATCC CRL-2299) were grown in DMEM media (containing 10% fetal bovine serum [FBS]) 
at 37 °C in a humidified 5% CO2 atmosphere23. Cells were passaged every 3–4 days. Culture media was changed 
after 24 h of passaging and every 2 days thereafter. Experiments were performed with cells from passages 26 to 34.
Oxygen glucose deprivation (OGD) and reoxygenation (RO) of bEnd.3 cells. bEnd.3 cells 
were seeded at a density of 7 × 104 cells/cm2 in 96-well plates or T75 tissue culture flasks (Greiner Bio-One), 
or at 4 × 104 cells/well in tissue culture inserts (translucent polyethylene terephthalate [PET], 0.4 μm pore size; 
Greiner Bio-One) and grown to confluence. Two-days post-confluent cells were washed twice with DMEM 
glucose-containing media to remove culture media, containing FBS, and replaced with either CSE (5%, 10%, 
20% or 40%) diluted in DMEM glucose-containing media or media alone (vehicle). Cells were incubated for 
1 h at 37 °C (5% CO2 atmosphere), washed twice with DMEM glucose-free media pre-equilibrated in OGD gas 
mixture for 5 mins (95% N2 and 5% CO2). Cells were then incubated for 4 h in a humidified hypoxia chamber 
(Biospherix, Lacona, USA; 95% N2, 5% CO2) in either OGD media containing CSE (5, 10, 20 or 40%) or OGD 
media alone (vehicle) (Fig. 1)23. A digital oxygen controller maintained the oxygen level at 0.3% and CO2 at 5% for 
the duration of the experiment. After 4 h of OGD, media was replaced with either vehicle or CSE (5%, 10%, 20% 
or 40%) diluted in glucose-containing, serum-free DMEM media (oxygenated with air) for a further 23 h incuba-
tion at 37 °C (5% CO2 atmosphere) (Fig. 1). For each OGD + RO experiment, time-controlled normoxic controls 
were run alongside by incubating cells for 27 h in CSE (5%, 10%, 20% or 40%) diluted in glucose-containing, 
serum-free DMEM media or media alone (vehicle) at 37 °C (5% CO2 atmosphere).
Measurement of cell viability of bEnd.3 cells. Morphological changes in bEnd.3 cells were assessed 
using phase contrast imaging. Briefly, bEnd.3 cells were seeded into 12-well plates and exposed to either normoxic 
or OGD + RO conditions, as described above, and treated with either vehicle or CSE (5, 10, 20 or 40%). Cells were 
then imaged using a microscope (Nikon Eclipse TS100, Japan) at ×100 magnification and image capture camera 
(Infinity 3 Lumenera, Canada). To measure cell viability a 3-(4,5 dimethylthiazol-2-yl)-5-(3-carboxymethoxyp
henyl)-2-(4-sulfophenyl)-2H-tetrazolium salt (MTS) assay (Promega, Australia) was performed as previously 
Figure 1. Flow chart depicting Oxygen glucose deprivation (OGD) and reoxygenation (RO) of bEnd.3 cells. 
Two days post-confluent bEnd.3 cells were pre-treated with either media alone (vehicle) or CSE (5, 10, 20 
or 40%) for 1 hour. Cells were then incubated for 4 hours in a hypoxic chamber in either glucose-free media 
containing CSE or OGE alone (vehicle). followed by oxygen glucose deprivation (OGD) with glucose-free 
vehicle or CSE for 4 hours in a hypoxic chamber. After 4 h of OGD, media was replaced with glucose-containing 
media (oxygenated with air) for a further 23 h incubation at 37 °C (5% CO2 atmosphere) (Fig. 1). For each 
OGD + RO experiment, time-controlled normoxic controls were run alongside by incubating cells for 27 h in 
CSE diluted in glucose-containing media or media alone (vehicle).
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described23. bEnd.3 cells were seeded into clear 96-well plates (Greiner, Bio-One) and exposed to OGD + RO or 
normoxic conditions with either vehicle or CSE (5, 10, 20 or 40%) treatment, as described above. Following RO, 
bEnd.3 cells were washed twice with pre-warmed Krebs-HEPES buffer [composed of (in mmol/L) 99 NaCl, 4.7 
KCl, 1.2 MgSO4, 1.0 KH2PO4, 19.6 NaHCO3, 11.2 Glucose 20 Na-HEPES and 2.5 CaCl2, pH = 7.4] prior to incu-
bating with the MTS solution for 1 h at 37 °C (5% CO2). A BMG Clariostar plate reader (BMG Labtech, Germany) 
was used to measure absorbance at a wavelength of 490 nm.
Measurement of paracellular permeability of bEnd.3 cells. Paracellular permeability was assessed 
by measuring the diffusion of 70 kDa fluorescein isothiocynate (FITC)-dextran (Sigma) across monolayer cul-
tures of bEnd.3 cells, as previously described23,24. Tissue culture inserts (0.4 μm pore size; Greiner Bio-One) 
were fitted into 24-well culture plates (Greiner Bio-One) and then pre-soaked with culture media in both the 
upper ‘apical’ chamber and lower chamber 1 h prior to seeding. bEnd.3 cells were subsequently seeded into the 
upper chamber in culture media as above. Culture media was replaced at this time and after 24 hours. Two-days 
post-confluent, bEnd.3 cells were exposed to OGD + RO or normoxic conditions with either vehicle or CSE 
(10%) treatment, as described above. Following RO, pre-warmed Krebs-HEPES buffer was replaced in the lower 
chamber of fresh wells and inserts transferred into these wells. Both the upper and lower chambers were then 
washed with pre-warmed Krebs-HEPES buffer twice and then FITC-dextran (1 mg/mL) was added to the upper 
chamber and left to incubate for 1 h at 37 °C (5% CO2). Duplicate samples from the lower chamber were removed 
and transferred into a black 96-well plate (PerkinElmer, Australia). Using a BMG Clariostar plate reader, fluores-
cence intensity was measured at an excitation wavelength of 492 nm and emission wavelength of 518 nm.
Measurement of superoxide levels in bEnd.3 cells. bEnd.3 cells were seeded into a white 96-well plate 
(PerkinElmer) and exposed to OGD + RO or normoxic conditions with either vehicle or CSE (5, 10, 20 or 40%) 
treatment, as described above. Following RO, L-012 (100 μmol/L)24,25 was added to each well and photon counts 
measured using a BMG Clariostar plate reader (45 cycles, 3 seconds per well).
Measurement of hydrogen peroxide production by bEnd.3 cells. bEnd.3 cells were seeded into a 
black 96-well plate (PerkinElmer) and exposed to OGD + RO or normoxic conditions with either vehicle or CSE 
(10%) treatment, as described above. Cells were treated with 15 μmol/L Amplex Red® reagent (10H-Phenoxazine-
3,7-diol, 10-acetyl- 119171-73-2) and 0.1 U/mL horseradish peroxidase (HRP) (Thermofisher Scientific)25. 
Amplex red and HRP were also added to hydrogen peroxide standards (0.000, 0.078, 0.156, 0.312, 0.625 and 
1.25 μmol/L). Fluorescence was then measured using a BMG Clariostar plate reader (121 cycles, 40 s per well) at 
emission filter 590 nm and excitation filter 530 nm.
RT-PCR. bEnd.3 cells were seeded into T75 cell culture flasks (Greiner Bio-One). Two-days post-confluent 
bEnd.3 cells were exposed to OGD + RO or normoxic conditions with vehicle or CSE (10%) treatment, as 
described above. Following RO, flasks were washed with 0.01 M phosphate buffered saline (PBS) twice and cells 
scraped off with 0.01 M PBS. RNA was extracted using the Qiagen RNase-free DNase kit (Qiagen) as per man-
ufacturer’s instructions. Both the purity and yield of RNA were quantified using a Nanodrop 2000 spectropho-
tometer (Thermofisher Scientific). cDNA was synthesised using a QuantiTect Reverse Transcription kit (Qiagen). 
QuantiFast SYBR® Green primers were used to measure Nox1 (NM_172203), Nox2 (NM_007807) and Nox4 
(NM_015760), SOD1 (NM_011434), SOD2 (NM_013671), SOD3 (NM_011435), Gpx-1 (NM_008160), and the 
housekeeping gene 18S (NR_003278). TaqMan® Universal Master Mix (Applied Biosystems) and mouse-specific 
TaqMan® Gene Expression assays (Applied Biosystems) were used to measure IL-4 (NM_021283.3), IL-1β 
(NM_008361.3), TNF-α (NM_013693.3), IFN-γ (NM_008337.3), IL-6 (NM_031168.1), TGF-β (NM_011577.1) 
and the housekeeping gene 18S (NR_003278.3) via a QuantStudioTM 7 Flex Real-Time PCR System (Applied 
Biosystems). Data were normalized to ribosomal 18s and represented relative to expression levels in normoxic 
vehicle control samples using the 2−ΔΔCt method26.
Data and statistical analyses. All statistical analysis was performed using GraphPad Prism 6 (GraphPad 
Software, Version 6.07, La Jolla, CA, USA). Results are represented as mean ± SEM and a P < 0.05 was consid-
ered to be statistically significant. Normoxic groups were compared using a Student’s unpaired t-test. A one-way 
ANOVA with a Bonferroni post-hoc test was performed for OGD + RO groups for FITC-dextran passage, cell 
viability, superoxide production, hydrogen peroxide production, and mRNA expression.
Results
Effect of CSE on cell viability of bEnd.3 cells. Treatment of normoxic or OGD + RO bEnd.3 cells with 
either 5 or 10% CSE resulted in no obvious morphological changes compared with vehicle-treated cells (Fig. 2A). 
However, 20% or 40% CSE resulted in a loss of their typical spindle-shape appearance as well as visible cell retrac-
tion (Fig. 2A). 5, 10, or 20% CSE had no significant effect on the viability of either normoxic or OGD + RO 
bEnd.3 cells relative to vehicle-treated cells (Fig. 2B,C, P > 0.05, n = 6–8), whereas 40% CSE decreased cell viabil-
ity by ~50% (Fig. 2B,C, P < 0.05).
Effect of CSE on paracellular permeability of bEnd.3 cells. Treatment of normoxic bEnd.3 cells with 
10% CSE significantly increased FITC-dextran passage (~2 fold) and thus endothelial cell paracellular permea-
bility, relative to vehicle-treated normoxic cells (Fig. 3A, P < 0.05, n = 6–8).
Exposure of bEnd.3 cells to OGD + RO significantly increased paracellular permeability (~4-fold) relative to 
normoxic controls (Fig. 3B, P < 0.05, n = 6–8). Furthermore, pre-treatment of cells with 10% CSE exacerbated 
(~2-fold) this hyperpermeability relative to vehicle-treated OGD + RO cells (Fig. 3B, P < 0.05, n = 8).
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Figure 2. Effect of cigarette smoke extract (CSE: 5, 10, 20, and 40%) on the morphology and cell viability of 
bEnd.3 cells exposed to normoxic or OGD + RO conditions. Phase contrast images of normoxic (top panel) 
and OGD + RO (bottom panel) bEnd.3 cells (representative of n = 3, A). Quantification of cell viability of 
normoxic (B) and OGD + RO (C) bEnd.3 cells. Results are represented as of vehicle-treated cells and are given 
as mean ± SEM (n = 6–8). *P < 0.05 vs. vehicle-treated cells (One-way ANOVA with Bonferroni post-hoc test).
Figure 3. Effect of cigarette smoke extract (CSE: 10%) on the paracellular permeability of bEnd.3 cells exposed 
to normoxic (A) or OGD + RO conditions (B). Results are expressed as fold-change in FITC-dextran passage 
relative to either vehicle-treated cells (A) or normoxic controls (B) and are given as mean ± SEM (n = 6–8). 
*P < 0.05 vs. vehicle-treated cells (A, Student’s unpaired t-test; B, #P < 0.05 vs. normoxic controls (One-way 
ANOVA with Bonferroni post-hoc test).
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Effect of CSE on superoxide and hydrogen peroxide levels in bEnd.3 cells. Using L-012 chemi-
luminescence and the Amplex Red fluorescence assay, we next assessed whether the effect of CSE on BBB per-
meability is associated with alterations in the production of superoxide and/or hydrogen peroxide, which both 
influence BBB integrity. Treatment of normoxic bEnd.3 cells with 5% CSE had no significant effect on superoxide 
levels (Fig. 4A, P > 0.05, n = 5), whereas superoxide levels were significantly lower in cells treated with 10% or 
20% CSE (Fig. 4A, P < 0.05, n = 6). Treatment of normoxic bEnd.3 cells with 10% CSE had no significant effect on 
hydrogen peroxide levels (Fig. 4C, P > 0.05, n = 5).
Consistent with our previous work24, superoxide levels in bEnd.3 cells were markedly elevated (~47%) after 
exposure to OGD + RO when compared with normoxic controls (Fig. 4B, P < 0.05, n = 6). Furthermore, there 
was a trend for hydrogen peroxide levels to also be elevated (Fig. 4D, P > 0.05, n = 5). By contrast, superoxide 
levels were not elevated after OGD + RO in cells treated with either 10% or 20%. In fact, superoxide levels were 
significantly lower compared with vehicle-treated OGD + RO cells (Fig. 4B, P < 0.05, n = 6). Hydrogen perox-
ide levels were also significantly lower in cells treated with 10% CSE relative to vehicle-treated OGD + RO cells 
(Fig. 4D, P < 0.05, n = 5).
Effect of CSE on mRNA expression of Nox catalytic subunits, SOD, and Gpx-1. Using RT-PCR, 
we next assessed whether the effect of CSE on ROS levels is associated with altered expression levels of Nox 
oxidase catalytic subunits (Nox1, Nox2, and Nox4) and/or antioxidant enzymes (SOD1-3, Gpx-1). 10% CSE sig-
nificantly increased Nox1, Nox4, SOD1, SOD2, and Gpx-1 mRNA expression in normoxic bEnd.3 cells relative 
to vehicle-treated cells (Figs 5A,C, 6A,B,D, P < 0.05, n = 8), whereas Nox2 and SOD3 expression levels were com-
parable between the two groups (Figs 5B & 6C, P > 0.05, n = 8).
Exposure of bEnd.3 cells to OGD + RO increased Nox1 and Nox4 mRNA expression relative to normoxic 
controls (Fig. 5D,F, P < 0.05, n = 8), but had no significant effect on expression levels of the SODs and Gpx-1 
(Fig. 6E–H, P > 0.05, n = 8). 10% CSE significantly increased Nox1 and Nox4 expression in OGD + RO cells 
relative to normoxic controls, and there was a trend for an increase in expression levels of the three Nox isoforms 
relative to vehicle-treated OGD + RO cells (Fig. 5D–F, P > 0.05, n = 8). 10% CSE also significantly increased 
expression of SOD1, SOD2, and Gpx-1 in OGD + RO cells relative to vehicle treated normoxic, and OGD + RO 
Figure 4. Effect of cigarette smoke extract (CSE: 5, 10, and 20%) on superoxide and hydrogen peroxide levels in 
bEnd.3 cells exposed to normoxic (A,C) or OGD + RO conditions (B,D). Results are expressed as a percentage of 
either vehicle-treated cells (A, C) or normoxic controls (B, D) and are given as mean ± SEM (n = 5–6). *P < 0.05 
vs. vehicle-treated cells, #P < 0.05 vs. normoxic controls (One-way ANOVA with Bonferroni post-hoc test).
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Figure 5. Effect of cigarette smoke extract (CSE: 10%) on mRNA expression of Nox1, Nox2, and Nox4 in 
bEnd.3 cells exposed to normoxic (A–C), or OGD + RO (D–F) conditions. Results are expressed as fold-change 
relative to either vehicle-treated cells (A–C) or normoxic controls (D–F) and are given as mean ± SEM (n = 8). 
*P < 0.05 vs. vehicle-treated cells (Student’s unpaired t-test), #P < 0.05 vs. normoxic controls (One-way ANOVA 
with Bonferroni post-hoc test).
Figure 6. Effect of cigarette smoke extract (CSE: 10%) on mRNA expression of SOD1, SOD2, SOD3, and Gpx-1 
in bEnd.3 cells exposed to normoxic (A–D), or OGD + RO (E–H) conditions. Results are expressed as fold-
change relative to either vehicle-treated cells (A–C) or normoxic controls (D–F) and are given as mean ± SEM 
(n = 8). *P < 0.05 vs. vehicle-treated cells (A–D, Student’s unpaired t-test; (E–H), One-way ANOVA with 
Bonferroni post-hoc test). #P < 0.05 vs. normoxic controls (One-way ANOVA with Bonferroni post-hoc test).
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cells (Fig. 6E,F,H, P < 0.05, n = 8). By contrast, Nox2 and SOD3 expression were comparable between groups 
(Figs 5E and 6G, P > 0.05, n = 8).
Effect of CSE on mRNA expression of inflammatory cytokines. CSE (10%) caused a significant 
increase in TGF-β mRNA expression (Fig. 7A) and a trend for an increase in IL-6 mRNA expression (Fig. 7B) 
in normoxic cells. However, CSE significantly increased TGF-β and IL-6 mRNA expression in OGD + RO cells 
(Fig. 7C,D, P < 0.05, n = 6). IL-4, IL-1β, TNF-α, and IFN-γ mRNA were undetectable in all normoxic and 
OGD + RO experimental groups (data not shown).
Discussion
This study aimed to determine whether CSE worsens ischaemia-induced BBB disruption in vitro by triggering oxi-
dative stress and/or inflammation. We found that the loss of BBB integrity following ischaemic/reperfusion-like 
conditions (OGD + RO) was indeed significantly worsened by CSE; however, contrary to our hypothesis this was 
not associated with elevated ROS levels. In fact, levels of superoxide and hydrogen peroxide were markedly lower 
in response to CSE, possibly because of upregulated antioxidant defence. Lastly, CSE increased the expression 
of pro-inflammatory cytokines in cerebral endothelial cells exposed to ischaemic/reperfusion-like conditions. 
Collectively, these results suggest that acute cigarette smoke exposure worsens BBB disruption after stroke poten-
tially via inflammatory mechanisms. Whilst in vivo studies are needed, these findings raise the possibility that the 
increased stroke risk and severity in smokers (and potentially COPD patients) might relate, at least in part, to the 
deleterious effect of cigarette smoke on BBB integrity.
Cigarette smoking is a risk factor for stroke and is linked to worse stroke outcomes27. Findings from this in 
vitro study and previously published work17,19,20 show that CSE, which contain the soluble components of cigarette 
smoke, causes dysfunction of the cerebrovascular endothelium (in the absence of ischaemia-like conditions). 
Indeed, using a concentration of CSE that does not induce overt endothelial cell death, we show here that acute 
exposure of monolayers of normoxic cerebral endothelial cells to CSE markedly increased paracellular permeabil-
ity, indicative of BBB disruption. These findings are consistent with studies showing that CSE causes a loss of BBB 
integrity in monolayers of human cerebral endothelial cells (hCMEC/D3) in association with altered expression of 
tight junction proteins (e.g. ZO-1, occludin, VE-cadherin and claudin-5)17,19,20. Cerebral endothelial dysfunction 
Figure 7. Effect of cigarette smoke extract (CSE: 10%) on mRNA expression of TGF-β and IL-6 in bEnd.3 cells 
exposed to normoxic (A,B), or OGD + RO (C,D) conditions. Results are expressed as fold-change relative to 
either vehicle-treated cells (A,B) or normoxic controls (C,D) and are given as mean ± SEM (n = 6). *P < 0.05 
vs. vehicle-treated cells (Student’s unpaired t-test), #P < 0.05 vs. normoxic controls (One-way ANOVA with 
Bonferroni post-hoc test).
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(particularly at the level of the BBB) contributes to and exacerbates ischaemic brain injury28. Therefore, the pri-
mary focus of this study was to test whether cigarette smoking influences stroke pathogenesis, at least in part, 
by worsening ischaemia-induced BBB disruption. We tested this using a well characterised in vitro BBB stroke 
model, which produces many of the key features of BBB disruption in vivo including paracellular hyperpermea-
bility, tight junction protein degradation, and MMP-expression23,24. Indeed, in this study we found that exposure 
of cerebral endothelial cells to OGD + RO caused a marked loss of BBB integrity. The new finding from these 
experiments however was that the BBB disruption following ischaemic/reperfusion-like conditions was signif-
icantly worsened by prior treatment with CSE. Together these results strengthen evidence that acute cigarette 
smoking triggers BBB disruption per se, and show for the first time that this in turn might exacerbate the loss of 
BBB function and integrity after stroke.
Oxidative stress and inflammation both contribute to the complex mechanisms of BBB disruption after 
cerebral ischaemia and reperfusion. Cigarette smoke contains over 4000 chemical compounds including ROS, 
reactive nitrogen species (RNS), nitric oxide (NO), and free radicals of organic compounds11. In addition to 
these relatively short-lived ROS/RNS, cigarette smoke contains more stable substances that have the potential to 
increase ROS production including saturated and unsaturated aldehydes, unsaturated ketones, and nicotine29,30. 
Some of these compounds have been shown to react with thiol groups involved in the regulation of enzymes such 
as the ROS generating Nox oxidases29,30. In addition to triggering oxidative stress and inflammation in the lungs, 
oxidants and more stable compounds can pass into the circulation and initiate oxidative stress and inflammation 
in cells and tissues remote from the primary site of exposure6. Indeed, previous studies have shown that CSE 
elevates ROS levels in various cell types (e.g. neurons, glial, and endothelial and vascular smooth muscle cells 
of systemic origin) via Nox oxidase activation, enzymes that a major sources of ROS in cerebral vessels25,31,32. 
We therefore postulated that CSE worsens BBB disruption after OGD + RO by augmenting ROS levels and/or 
triggering an inflammatory response. Contrary to our hypothesis, although superoxide levels were elevated in 
control cells after OGD + RO, we found that prior treatment with CSE did not elevate levels further. In fact, 
despite evidence for increased gene expression of Nox1 and Nox4 catalytic subunits, superoxide levels in CSE 
treated cells after OGD + RO were in fact ~50% lower than controls. Consistent with this lower level of superox-
ide, hydrogen peroxide (the downstream metabolite of superoxide) levels were similarly lower in CSE treated cells 
after OGD + RO. Thus, these in vitro findings suggest that cigarette smoke exposure does not trigger or worsen 
BBB disruption by elevating ROS levels in cerebral endothelial cells.
Some studies have shown that antioxidant defence mechanisms are upregulated in endothelial cells in 
response to exposure to CSE. For example, acute exposure of human cerebral endothelial cells to CSE upregulates 
the expression of nuclear-factor (erythroid derived 2) related factor-2 (Nrf2)19. Nrf2 is one of the major tran-
scription factors regulating the antioxidant defence response to oxidative stress, including the upregulation of the 
enzymes responsible for ROS metabolism (SODs, catalase, and Gpx1)33. Consistent with this, we found evidence 
of increased expression of SOD1, SOD2, and Gpx1 in response to CSE. We propose that upregulation of these 
antioxidant enzymes occurs in response to, and to counteract the oxidative stress caused by cigarette smoking. It 
remains to be determined, however, if this protection is sustained over longer periods of cigarette smoke exposure 
or whether the oxidative stimuli in cigarette smoke overcomes the protective antioxidant mechanisms of cerebral 
endothelial cells.
We then went on to explore whether the worsening of CSE-induced BBB disruption was associated with 
increased inflammatory gene expression. We found that IL-4, IL-1β, TNF-α, and IFN-γ mRNA were all unde-
tectable. Similarly, a study found that IL-1β and TNF-α levels were below the level of detection (ELISA) in 
hCMEC/D3 cells following exposure to CSE34. In contrast to these cytokines, we found that IL-6 and TGF-β 
were significantly greater in CSE-treated cerebral endothelial cells after OGD + RO. However, whether this 
translates to increased cytokine levels remains to be determined. Furthermore, future experiments should 
be performed to determine whether elevated gene expression of IL-6 and TGF-β in response to CSE leads to 
increased cytokine-mediated signaling, e.g. phosphorylation of TGF-β receptor-regulated Smad proteins. Our 
findings are however consistent with previous studies showing that CSE promotes cytokine production (e.g. IL-6, 
IL-8, TGF-β) and the expression of adhesion molecules (e.g. vascular endothelial adhesion molecule-1, platelet 
endothelial cell adhesion molecule-1) in endothelial cells19,34. The roles of IL-6 and TGF-β in ischaemic stroke and 
BBB disruption are however not fully elucidated. IL-6 and TGF-β have been shown to increase the paracellular 
permeability of monolayers of cerebral endothelial cells in vitro by triggering a loss of tight junction proteins35,36. 
Consistent with this, inhibiting the effects of IL-6 with neutralizing antibodies attenuates ischaemia-induced BBB 
disruption in a hypoxic-ischaemic brain injury model37. By contrast, IL-6 has been reported to support the integ-
rity of the BBB in a rat model of cerebral ischaemia38. Thus, future studies are needed to fully determine whether 
these cytokines contribute to the deleterious effects of cigarette smoke exposure on BBB integrity.
This study used a well-characterised and utilized immortalised cerebral endothelial cell line which displays 
many of the key features of the BBB such as the expression of key tight junction proteins, as well as the expression 
of key endothelial cell markers23. Monolayers of bEnd.3 cells are known to exhibit moderate paracellular perme-
ability to high molecular weight molecules and have TEER readings ranging from 100–140 Ω cm2 39,40, which is 
similar to that of primary cultures from several species (50–180 Ω cm2)41. Furthermore, bEnd.3 cells have the 
advantage of being cost effective compared with immortalised human cell lines or primary cerebral endothelial 
cells. Nevertheless, primary cerebral endothelial cells have the closest similarity to the BBB phenotype in vivo at 
low passage numbers. Thus, future studies should be performed to validate our findings in monolayers of primary 
cerebral endothelial cells, and/or using an immortalised human cerebral endothelial cell line.
In summary, the study found that cigarette smoke exposure worsens ischaemia-induced BBB disruption. 
Whilst cigarette smoke exposure increased the gene expression of Nox oxidases this did not translate to ele-
vated levels of either superoxide or its downstream metabolite hydrogen peroxide, possibly because of upreg-
ulated antioxidant defence. Future studies should examine whether this protection is sustained chronically or 
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whether cigarette smoke exposure overcomes the protective antioxidant mechanisms of cerebral endothelial cells. 
Lastly, we found evidence of increased proinflammatory gene expression in response to cigarette smoke expo-
sure, suggesting the involvement of inflammatory mechanisms. The deleterious effect of CSE on BBB integrity 
might be consistent with the occurrence of a biological process known as endothelial to mesenchymal tran-
sition (EndoMT). Similar to airway epithelial to mesenchymal transition (EMT), EndoMT is a complex pro-
cess whereby endothelial cells lose their specific markers such as the adheren junction protein VE-cadherins42,43, 
which is important for maintaining BBB integrity. Under chronic oxidative damage and inflammation (notably 
TGF-β) EndoMT can be initiated42,44. EMT is an active process in smokers and COPD patients45,46. Moreover, 
there is evidence that EndoMT might also be active in the pulmonary vasculature during COPD47. Thus, future 
studies could explore whether CSE initiates EndoMT in the cerebral endothelium and whether such a process 
contributes to the deleterious effects of CSE on BBB integrity. In conclusion, although future in vivo studies are 
needed, our findings raise the possibility that the deleterious effect of cigarette smoke on BBB integrity may con-
tribute to stroke risk and severity in smokers and potentially COPD patients.
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